Johnson & Johnson

Jim Cramer defends Elon Musk's use of ketamine for depression: The CEO 'saved a lot of lives'
Health

Jim Cramer defends Elon Musk's use of ketamine for depression: The CEO 'saved a lot of lives'

CNBC’s Jim Cramer said Tuesday that Elon Musk’s disclosure that he takes prescription ketamine for depression was courageous and “saved a lot of people from killing themselves.” “I defend him as much as possible because there are many people who would never be brave enough to admit they take this drug,” Cramer said on ” […]

Read More
Nvidia and Johnson & Johnson to establish new AI programs for surgical procedure
Technology

Nvidia and Johnson & Johnson to establish new AI programs for surgical procedure

The New York Inventory Exchange welcomes Johnson & Johnson. NYSE Johnson & Johnson on Monday introduced it is operating with Nvidia to build and scale new artificial intelligence apps for operation.  J&J’s MedTech device and Nvidia strategy to integrate AI in just gadgets and platforms from pre-op to submit-op to assist guarantee that surgeons have […]

Read More
Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
Health

Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! The bitter legal battle […]

Read More
'This is the mental health moment': Innovation and M&A are helping to boost these stocks to new heights
Health

'This is the mental health moment': Innovation and M&A are helping to boost these stocks to new heights

There’s been a lot of chatter about the mental health crisis since the Covid-19 pandemic. Overall, 12 mental health disorders affect 970 million people around the world — or one in eight people, according to the Institute for Health Metrics and Evaluation’s Global Burden of Disease. That can mean anything from anxiety and depression to […]

Read More
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
Health

Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images A federal judge on Monday tossed a lawsuit brought by a major pharmaceutical industry lobbying group and two other organizations, which challenged […]

Read More
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
Health

Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey on issuing subpoenas for pharmaceutical company CEOs to testify regarding drug prices, in the Capitol, Jan. 25, 2024. Bill Clark | Cq-roll Call, Inc. | Getty Images Senators will question the CEOs of Johnson & Johnson, Merck and Bristol Myers Squibb on […]

Read More
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
Health

Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com.  Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks […]

Read More
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Health

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium.  NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put tens of billions of dollars in sales at risk between now and 2030, as blockbuster drugs will tumble off a […]

Read More
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Health

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

US Senator Bernie Sanders, Independent of Vermont, speaks during a rally by the People’s Action, protesting pharmaceutical companies’ lobbying against allowing Medicare to negotiate lower prescription drug prices, outside Pharmaceutical Research and Manufacturers of America (PhRMA) headquarters in Washington, DC, September 21, 2021. Saul Loeb | AFP | Getty Images The CEOs of Merck and […]

Read More
Johnson & Johnson to settle talc baby powder investigation, will reportedly pay 0 million
Health

Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million

In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San Anselmo, California.  Justin Sullivan | Getty Images Johnson & Johnson has reached a tentative settlement to resolve an investigation by more than 40 states into claims that the company misled patients about the safety of […]

Read More